IGC Pharma, Inc.
corporate_fare Company Profile
IGC Pharma, Inc. (NASDAQ:IGC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for IGC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Recent SEC coverage for IGC spans 10-Q.
Recent high-impact activity:
- IGC Pharma Narrows Q3 Loss, but Cash Falls to $377K Ahead of CALMA Topline
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 395,551 shares in IGC as of the October 30, 2026 settlement, a 37.8% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 27.1% of IGC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.